Abstract
Objective To assess if taking outpatient antihypertensives prior to stroke onset influences acute stroke inpatient mortality.
Design Retrospective chart review of 417 adults admitted for acute stroke from January 2013 to December 2014.
Setting Single tertiary hospital in Zimbabwe.
Participants Of the 417 adult patients admitted with stroke, 40 were excluded (2 rheumatic heart disease, 10 transient ischemic attacks, and 28 incomplete documentation).
Methods Study registry was obtained from acute stroke billing codes in the hospital database and SPSS 23 was used for analysis.
Primary and secondary outcomes and measures Inpatient mortality was the primary outcome and determination of reported outpatient antihypertensive regimens was the secondary outcome.
Results Among the 377 patients in the final analysis the mean age was 65.8 ± 15.7 years, 64.5% were female, 68.9% had known hypertension, and 51.2% were taking outpatient antihypertensives. Overall inpatient mortality was 134 (35.5%, 95 CI: 30.6 -39.6). Mortality was similar among patients taking and not taking outpatient antihypertensives, 39.2% and 31.5% respectively (X2 test, p=0.4; 95 CI 31.3-40.3). Four most common antihypertensive regimens were: calcium channel blocker/thiazides dual therapy, thiazide monotherapy, calcium channel blocker monotherapy, and calcium channel blocker/ angiotensin converting enzyme inhibitor or angiotensin receptor blocker dual therapy.
Conclusions and Relevance Only half of the patients admitted for stroke were taking antihypertensives prior to stroke onset. There was no statistical significance in inpatient mortality associated with taking antihypertensives prior to developing stroke, suggesting either the limited impact of outpatient antihypertensives on in-hospital mortality or low outpatient antihypertensive adherence.
Strengths and Limitations of the Study
We studied a large group of patients at a major safety net center in a region of Zimbabwe that is chronically under-represented in stroke studies
The degree of outpatient hypertension control among patients on antihypertensives could not be determined due to lack of access to outpatient records
Poor medical knowledge, altered mental status from stroke, and the absence of an integrated outpatient pharmacy database limited accurate medication reconciliations
Lack of neuroimaging data limited the ability to discern between ischemic versus hemorrhagic strokes and rule out structural stroke mimics such as intracranial tumors
Inconsistent and incomplete documentation practices such as omission of vital sign documentation on admission limited data collection
Funding Statement This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing Interests None of the authors have any competing interests to declare.
Statement of Ethics Approval This research was approved by the ethics body of Mpilo Central Hospital on 21 June 2016 as part of the mandate to assess The Burden of Hypertension and its Co-morbidities in Patients Admitted at Mpilo Central Hospital.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved by the ethics body of Mpilo Central Hospital on 21 June 2016 as part of the mandate to assess The Burden of Hypertension and its Co-morbidities in Patients Admitted at Mpilo Central Hospital.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Co-author: Mr. Desmond Mwembe (NUST Faculty of Statistics, Bulawayo, Zimbabwe)
Principal Investigator: Dr. Rudo Gwini (Mpilo Central Hospital, Bulawayo, Zimbabwe and NUST Faculty of Medicine)
Data Availability
All raw data is available via email in Excel spreadsheet format upon reasonable request.